Regenerative Therapies to Restore Interneuron Disturbances in Experimental Models of Encephalopathy of Prematurity
Autor: | Josine E G Vaes, Marthe Kaal, Chantal M Kosmeijer, Myrna J V Brandt, Manon J.N.L. Benders, Cora H. Nijboer, Rik van Vliet |
---|---|
Rok vydání: | 2020 |
Předmět: |
Vasoactive intestinal peptide
Hippocampal formation Systemic inflammation Hippocampus lcsh:Chemistry Pregnancy GABAergic Neurons lcsh:QH301-705.5 Spectroscopy Cerebral Cortex biology musculoskeletal neural and ocular physiology neurodevelopmental disorders insulin-like growth factor I General Medicine Computer Science Applications medicine.anatomical_structure Hypoxia-Ischemia Brain Female medicine.symptom medicine.medical_specialty Interneuron regenerative medicine Mesenchymal Stem Cell Transplantation Inhibitory postsynaptic potential Article Catalysis Inorganic Chemistry Internal medicine medicine Animals Rats Wistar Physical and Theoretical Chemistry Social Behavior Molecular Biology Administration Intranasal mesenchymal stem cells interneurons business.industry Dentate gyrus Organic Chemistry preterm birth encephalopathy of prematurity Oligodendrocyte Mice Inbred C57BL Disease Models Animal Endocrinology lcsh:Biology (General) lcsh:QD1-999 nervous system biology.protein business Parvalbumin |
Zdroj: | International Journal of Molecular Sciences Volume 22 Issue 1 International Journal of Molecular Sciences, Vol 22, Iss 211, p 211 (2021) |
ISSN: | 1422-0067 |
DOI: | 10.3390/ijms22010211 |
Popis: | Encephalopathy of Prematurity (EoP) is a major cause of morbidity in (extreme) preterm neonates. Though the majority of EoP research has focused on failure of oligodendrocyte maturation as an underlying pathophysiological mechanism, recent pioneer work has identified developmental disturbances in inhibitory interneurons to contribute to EoP. Here we investigated interneuron abnormalities in two experimental models of EoP and explored the potential of two promising treatment strategies, namely intranasal mesenchymal stem cells (MSCs) or insulin-like growth factor I (IGF1), to restore interneuron development. In rats, fetal inflammation and postnatal hypoxia led to a transient increase in total cortical interneuron numbers, with a layer-specific deficit in parvalbumin (PV)+ interneurons. Additionally, a transient excess of total cortical cell density was observed, including excitatory neuron numbers. In the hippocampal cornu ammonis (CA) 1 region, long-term deficits in total interneuron numbers and PV+ subtype were observed. In mice subjected to postnatal hypoxia/ischemia and systemic inflammation, total numbers of cortical interneurons remained unaffected however, subtype analysis revealed a global, transient reduction in PV+ cells and a long-lasting layer-specific increase in vasoactive intestinal polypeptide (VIP)+ cells. In the dentate gyrus, a long-lasting deficit of somatostatin (SST)+ cells was observed. Both intranasal MSC and IGF1 therapy restored the majority of interneuron abnormalities in EoP mice. In line with the histological findings, EoP mice displayed impaired social behavior, which was partly restored by the therapies. In conclusion, induction of experimental EoP is associated with model-specific disturbances in interneuron development. In addition, intranasal MSCs and IGF1 are promising therapeutic strategies to aid interneuron development after EoP. |
Databáze: | OpenAIRE |
Externí odkaz: |